Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals is a publicly traded biopharmaceutical company specializing in the development of RNA interference (RNAi) therapeutics for diseases such as hepatitis B, alpha-1 antitrypsin deficiency, and cardiovascular conditions. The company has a robust pipeline with multiple clinical-stage candidates and strategic partnerships with major pharmaceutical firms, positioning it as a leader in RNAi-based drug development. Arrowhead is recognized for its innovative approach and expanding presence in the biotechnology sector.

Company Facts

• Headquarters: Pasadena, United States
• Founded: 2003
• Employees: 609
• Type: Public Corporation
• Website: https://www.arrowheadpharma.com
• Industries: Biotechnology, Pharmaceuticals, Healthcare, RNA Therapeutics